Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report)’s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.
Arno Therapeutics Stock Performance
Arno Therapeutics Company Profile
Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.
Read More
- Five stocks we like better than Arno Therapeutics
- What to Know About Investing in Penny Stocks
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- 10 Best Airline Stocks to Buy
- Nebius Group: The Rising Star in AI Infrastructure
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
